Toxicogenomics – A Drug Development Perspective - Genomic Biomarkers for Pharmaceutical Development - page 150

[192] Sawada H, Takami K, Asahi S. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its
induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci 2005;83(2):282-92.
[193] Sahu SC, editor. Toxicogenomics: a powerful tool for toxicity assessment. UK: Wiley; 2008.
[194] Cunningham ML, Lehman-McKeeman L. Applying toxicogenomics in mechanistic and predictive toxicology.
Toxicol Sci 2005;83(2):205-6.
[195] Burczynski ME, et al. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma
cells. Toxicol Sci 2000;58(2):399-415.
[196] Bulera SJ, et al. RNA expression in the early characterization of hepatotoxicants in wister rats by high-density
DNA microarrays. Hepatology 2001;33(5):1239-58.
[197] Minotti G, et al. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity
and cardiotoxicity. Pharmacol Rev 2004;56(2):185-229.
[198] IOM, Emerging Safety Science: Workshop Summary. Chapter 4: Screening Technologies II: Toxicogenomics
< http: // www.ncbi.nlm.nih.gov / books / NBK4060 / >; 2008 [accessed 21.01.13].
[199] Raman T, et al. Quality control in microarray assessment of gene expression in human airway epithelium.
BMC Genomics 2009;10:493.
[200] Thompson KL, et al. Characterization of the effect of sample quality on high density oligonucleotide microar-
ray data using progressively degraded rat liver RNA. BMC Biotechnol 2007;7:57.
[201] Archer KJ, et al. Application of a correlation correction factor in a microarray cross-platform reproducibility
study. BMC Bioinformatics 2007;8:447.
[202] Chen JJ, et al. Reproducibility of microarray data: a further analysis of microarray quality control (MAQC)
data. BMC Bioinformatics 2007;8:1-14.
[203] Shi LM, et al. The balance of reproducibility, sensitivity, and speciicity of lists of differentially expressed
genes in microarray studies. BMC Bioinformatics 2008;9(Suppl. 9):S10.
[204] Kadota K, Shimizu K. Evaluating methods for ranking differentially expressed genes applied to microArray
quality control data. BMC Bioinformatics 2011;12:227.
[205] Kurose K, et al. Quality requirements for genomic dna preparations and storage conditions for a high-density
oligonucleotide microarray. Biol Pharm Bull 2012;35(10):1846-8.
[206] McCall MN, et al. Assessing affymetrix GeneChip microarray quality. BMC Bioinformatics 2011;12:137.
[207] Schmidberger M, Vicedo E, Mansmann U. Empirical study for the agreement between statistical methods in
quality assessment and control of microarray data. Comput Stat 2011;26(2):259-77.
[208] Casciano DA, Woodcock J. Empowering microarrays in the regulatory setting. Nat Biotechnol 2006;
24(9):1103.
[209] < http://www.fda.gov/ScienceResearch/BioinformaticsTools/MicroarrayQualityControlProject/ >.
MAQC-II. FDA [accessed 12.01.13].
[210] Shi LM, et al. The microarray quality control (MAQC)-IIII study of common practices for the development
and validation of microarray-based predictive models. Nat Biotechnol 2010;28(8):827-U109.
[211] Shi LM, et al. The microarray quality control (MAQC) project shows inter- and intraplatform reproducibility
of gene expression measurements. Nat Biotechnol 2006;24(9):1151-61.
[212] Tong WD, et al. Evaluation of external RNA controls for the assessment of microarray performance. Nat
Biotechnol 2006;24(9):1132-9.
[213] Fu X, et al. Data governance in predictive toxicology: a review. J Cheminformatics 2011;3(1):24.
[214] Judson R. Public databases supporting computational toxicology. J Toxicol Environ Health B Crit Rev
2010;13(2-4):218-31.
[215] Judson RS, et al. Aggregating data for computational toxicology applications: the US environmental
protection agency (EPA) aggregated computational toxicology resource (ACToR) system. Int J Mol Sci
2012;13(2):1805-31.
[216] Davis AP, et al. The comparative toxicogenomics database: update 2011. Nucleic Acids Res
2011;39:D1067-D1072.
[217] Davis AP, et al. MEDIC: a practical disease vocabulary used at the comparative toxicogenomics database.
Database 2012.
[218] Uehara T, et al. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-
scale toxicogenomics database. Toxicol Appl Pharmacol 2011;255(3):297-306.
[219] Ganter B, et al. Development of a large-scale chemogenomics database to improve drug candidate selection
and to understand mechanisms of chemical toxicity and action. J Biotechnol 2005;119(3):219-44.